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meBACKGROUND Sleep duration and quality have been associated with increased cardiovascular risk. However,
large studies linking objectively measured sleep and subclinical atherosclerosis assessed in multiple vascular sites
are lacking.
OBJECTIVES The purpose of this study was to evaluate the association of actigraphy-measured sleep parameters
with subclinical atherosclerosis in an asymptomatic middle-aged population, and investigate interactions among sleep,
conventional risk factors, psychosocial factors, dietary habits, and inflammation.
METHODS Seven-day actigraphic recording was performed in 3,974 participants (age 45.8  4.3 years; 62.6% men)
from the PESA (Progression of Early Subclinical Atherosclerosis) study. Four groups were defined: very short sleep
duration <6 h, short sleep duration 6 to 7 h, reference sleep duration 7 to 8 h, and long sleep duration >8 h. Sleep
fragmentation index was defined as the sum of the movement index and fragmentation index. Carotid and femoral
3-dimensional vascular ultrasound and cardiac computed tomography were performed to quantify noncoronary
atherosclerosis and coronary calcification.
RESULTS When adjusted for conventional risk factors, very short sleep duration was independently associated with a
higher atherosclerotic burden with 3-dimensional vascular ultrasound compared to the reference group (odds ratio: 1.27;
95% confidence interval: 1.06 to 1.52; p ¼ 0.008). Participants within the highest quintile of sleep fragmentation
presented a higher prevalence of multiple affected noncoronary territories (odds ratio: 1.34; 95% confidence interval:
1.09 to 1.64; p ¼ 0.006). No differences were observed regarding coronary artery calcification score in the different
sleep groups.
CONCLUSIONS Lower sleeping times and fragmented sleep are independently associated with an increased risk
of subclinical multiterritory atherosclerosis. These results highlight the importance of healthy sleep habits for the
prevention of cardiovascular disease. (J Am Coll Cardiol 2019;73:134–44) © 2019 Published by Elsevier on behalf of the
American College of Cardiology Foundation.N 0735-1097/$36.00 https://doi.org/10.1016/j.jacc.2018.10.060
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135AB BR E V I A T I O N S
AND ACRONYM S
3D = 3-dimensional
CT = computed tomography
LSD = long sleep durationS leep is an essential physiological process thatprotects our physical and mental health. Sleepdeficiency is highly prevalent in Western soci-
eties, and epidemiological studies suggest that not
only short but also long sleep duration (LSD) is
related to an increased cardiovascular risk (1,2).SEE PAGE 145
RSD = reference sleep duration
SFI = sleep fragmentation
index
SSD = short sleep duration
VSSD = very short sleep
duration
VUS = vascular ultrasoundSeveral studies and meta-analyses have reported
associations between short sleep duration (SSD) and
hypertension (3,4), with some showing a relationship
with incident hypertension in subjects <65 years of
age (4,5). No such association has been found with
LSD (5). Recent meta-analyses have shown a 30%
increased risk of diabetes mellitus among subjects
sleeping <5 to 6 h/day, as well as in those who sleep
>8 h/day (6). In addition, SSD has been reported to
influence food intake and obesity (7).
Although sleep quality and duration have been
associated with the risk of coronary heart disease,
stroke (1), and subclinical atherosclerosis (8), most
studies rely on self-reported questionnaires of sleep
evaluation (8,9). The value of previous actigraphy-
based studies evaluating atherosclerotic burden is
limited because these were mostly small studies
(10–12), and they focused on patients with sleep dis-
orders, such as obstructive sleep apnea (OSA) (13,14).
Previous studies relying on objectively-assessed sleep
have shown that shorter sleep duration is associated
with greater carotid intima-media thickness in men
(15), and longer sleep duration is associated with a
lower coronary calcification incidence, which is
related to subclinical atherosclerosis (16). However,
studies using newer and more reliable imaging tech-
niques for measuring atherosclerosis are lacking.
Moreover, the association of multiterritory athero-
sclerosis and sleep has not been yet assessed.
The aim of this study was to evaluate the associa-
tion between actigraphy-measured sleep parameters
and subclinical atherosclerosis, investigating possible
interactions between sleep parameters, risk factors,
dietary habits, and inflammatory markers.
METHODS
STUDY POPULATION. PESA-CNIC (Progression of
Early Subclinical Atherosclerosis–Centro Nacional de
Investigaciones Cardiovasculares)-Santander is anresearch funding from the Instituto de Salud Carlos III, Spain (PIE16/00021 a
Janssen, and Novartis. All other authors have reported that they have no
to disclose.
Manuscript received July 17, 2018; revised manuscript received October 9, 2observational prospective cohort study that
recruited 4,184 male and female employees
of Santander Bank in Madrid from 40 to 54
years of age (17). All participants were free of
known cardiovascular disease (CVD). The
baseline visit included a fasting blood test,
urine sample, and a 12-lead electrocardio-
gram. Patients with a history of OSA at base-
line (n ¼ 77) and those without actigraphic
recording (n ¼ 133) were excluded from the
study. The final sample available for this
analysis consisted of 3,974 participants. Of
those, 3,804 were examined at baseline by 3-
dimensional (3D) vascular ultrasound (VUS) (170 were
excluded due to incomplete 3D VUS studies and
incomplete clinical data necessary for the adjusted
models) and 3,899 with noncontrast cardiac
computed tomography (CT) (75 were excluded
because of incomplete clinical data necessary for the
adjusted models).
ASSESSMENT OF CVD RISK FACTORS, METABOLIC
SYNDROME, AND DIETARY INTAKE. The partici-
pants’ medical history, traditional CVD risk factors,
lifestyle features (18), and physical examination
including anthropometric characteristics were recor-
ded. Obesity was defined as a body mass index
(BMI) $30 kg/m2. Metabolic syndrome was defined
according to the National Cholesterol Education Pro-
gram Adult Treatment Panel III criteria (19), which
require 3 or more of the following characteristics:
1) abdominal obesity, defined as a waist circumfer-
ence in men $102 cm and women $88 cm; 2) serum
triglycerides $150 mg/dl or drug treatment for
elevated triglycerides; 3) serum high-density lipo-
protein (HDL) cholesterol <40 mg/dl in men
and <50 mg/dl in women or drug treatment for low
HDL cholesterol; 4) blood pressure $130/85 mm Hg or
drug treatment for elevated blood pressure; and
5) fasting plasma glucose (FPG) $100 mg/dl or drug
treatment for high blood glucose. The Framingham
10-year and 30-year scores, as well as the Fuster-
BEWAT (20) score, were calculated in all study
participants. Additionally, to avoid the potential
confounding factor of underdiagnosed OSA, a modi-
fied STOP-BANG (Snoring, Tired, Observed apnea,
high blood Pressure, BMI >35 kg/m2, Age >50, Neck
circumference >43 cm in males and >41 cm innd PI17/01799), AstraZeneca, Bristol-Myers Squibb,
relationships relevant to the contents of this paper
018, accepted October 12, 2018.
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136females, and male Gender) questionnaire score
(mSTOP-BANG) was calculated and results were
adjusted for this variable. The STOP-BANG question-
naire evaluates the risk of sleep apnea and has been
proved to be a practical tool to screen for OSA (21).
The clinical data from the PESA study included all of
the necessary parameters to calculate the STOP-BANG
score except for the neck circumference, and there-
fore the results of an mSTOP-BANG score were
incorporated into our study.
All participants underwent a survey to complete
the computerized dietary history adapted to the
Spanish population, which was initially developed
and validated in the EPIC-Spain study (22,23). The
survey is based on a computer application and
is structured according to the episodes of intake
throughout the day (breakfast, midmorning, lunch,
snack, dinner, and ingestion between meals) (24,25).
Once the survey was completed, the software
provided information on foods consumed, caloric
intake, macronutrient and micronutrient intake, and
different forms of food preparation, as well as specific
eating habits. Regarding caffeinated drinks, partici-
pants were asked to report their daily intake in grams
including coffee, tea, cola drinks, and energy drinks.
Assuming an approximate density of 1 g/cm3, results
were converted to milliliters.
ASSESSMENT OF QUANTITY AND QUALITY OF
SLEEP. Actigraphic and self-reported sleep durations
were first analyzed as continuous variables and then
divided into multiple categories to achieve groups
of adequate sample sizes to reflect the possible
nonlinear (U- or J-shaped) associations between sleep
duration and risk outcomes. The quantity of sleep was
assessed by triaxial accelerometry, using Acti Trainers
accelerometers (Actigraph, Pensacola, Florida) placed
on the participant’s waist for 7 days. Based on the
last scientific statement from the American Heart
Association regarding the impact of sleep duration
on cardiometabolic health, a sleep duration of 7 to 8 h
was considered normal and participants within that
range were considered as the reference sleep duration
(RSD) group (26). The remaining groups included
participants with very short sleep duration (VSSD)
(<6 h), short sleep duration (SSD) (6 to 7 h), and long
sleep duration (LSD) (>8 h).
Sleep quality was assessed by the total sleep
Fragmentation Index (SFI), which is defined as
the sum of the movement index (MI) and the frag-
mentation index (FI). MI is the percentage of epochs
with y-axis counts >0 in the sleep period. FI is the
percentage of 1-min periods of sleep versus all
periods of sleep during the sleep period (27). Study
participants were divided into quintiles according tosleep fragmentation and those with less fragmented
sleep (first quintile) were considered to be the refer-
ence group. Additionally, participants completed the
Sleep Habits Questionnaire, which was developed
and validated by the Sleep Heart Health Study (28).
PSYCHOSOCIAL EVALUATION. The presence of
depressive symptoms was evaluated by the Center
for Epidemiological Studies-Depression (CES-D)
scale. It has been translated and validated in the
Spanish population (29), and has demonstrated high
sensitivity and specificity for the identification of
depressive symptoms in epidemiological studies.
Participants also completed the Perceived Stress Scale
(PSS) (30), which is widely used for measuring
nonspecific perceived stress.
ASSESSMENT OF SUBCLINICAL ATHEROSCLEROSIS.
PESA participants underwent 3D VUS studies using
a volumetric-linear array transducer to evaluate
plaque burden in the bilateral carotid and femoral
arteries. As there is currently no standard definition
for plaque presence using 3D VUS, noncoronary
atherosclerosis was defined as plaque presence using
the Manheim criteria for 2-dimensional VUS (31),
and the number of affected territories (1 to 4) was
also recorded. Cumulative plaque volume (burden,
in mm3) was quantified and divided into tertiles to
classify atherosclerosis as mild, moderate, or severe
(32). This 3D VUS method has already proven to be
accurate measuring plaque volumes in vitro and
in vivo (33). Moreover, atherosclerosis assessed by
3D VUS in the PESA cohort correlates with classic
cardiovascular risk factors, especially for femoral
arteries (32). A 16-slice CT scan was used to quantify
the Agatston coronary calcium score (CACS), which
was categorized as 0, <1, 1 to 100, 101 to 400, and
>400 (34).
All performed imaging tests were blind, and the
Centro Nacional de Investigaciones Cardiovasculares
conducted the analysis.
ASSESSMENT OF INFLAMMATORY BIOMARKERS. The
assessed inflammatory biomarkers included neutro-
phil count, P selectin, high-sensitivity C-reactive
protein (hs-CRP), and vascular cell adhesion molecule
(VCAM).
STATISTICAL ANALYSIS. Statistical analyses were
performed with SPSS software version 21.0 (IBM,
Armonk, New York). The population baseline char-
acteristics of the study are presented as percentages
for categorical variables and as the mean and SD for
continuous variables. Bonferroni (analysis of variance
with multiple testing correction) was used for
continuous variables, including p for trend values
for the general comparison of groups and specific
TABLE 1 Baseline Characteristics and Sleep Duration Measured by Actigraph
Total Sleep Time (Actigraph) Total VSSD <6 h SSD 6 to <7 h RSD 7 to <8 h (Ref) LSD $8 h p Value*
Number of participants 3,974 (100.0) 1,071 (27.0) 1,521 (38.3) 1,222 (30.7) 160 (4.0)
Age, yrs 45.8  4.3 46.6  4.3† 45.8  4.4† 45.1  4.0 44.5  4.0 <0.001
Men 62.6 74.0 65.2 52.0 43.1 <0.001
Smoking status 0.02
Never 39.4 33.9 41.2 41.7 41.5
Former 32.4 35.1 30.8 32.9 26.4
Social 7.5 7.3 7.4 7.4 10.1
Current 20.7 23.7 20.6 18.0 22.0
Alcohol intake, g/day 5.8 (1.5–12.6) 7.2 (1.7–14.1) 6.3 (1.8–13.2) 4.7 (1.0–11.0) 4.1 (0.9–10.4) <0.001
MVPA, min/day 46.8  20.7 47.9  22.0 47.2  20.8 46.3  19.6 40.6  17.0† 0.13
Married 75.9 74.6 76.4 77.0 71.1 0.06
BMI, kg/m2 26.1  3.79 26.9  3.9† 26.2  3.9† 25.5  3.8 24.5  3.6† <0.001
Systolic BP, mm Hg 116.2  12.5 117.9  12.3† 116.6  12.2† 114.3  12.6 114.0  13.7 <0.001
Diastolic BP, mm Hg 72.4  9.4 73.6  9.5† 72.5  9.4† 71.4  9.1 71.7  9.6 <0.001
Hypertension 12.1 13.9 12.5 10.0 10.0 0.03
Antihypertensive drugs 7.3 9.2 7.2 6.0 5.0 0.02
Fasting glucose, mg/dl 90.4  13.7 92.1  13.1† 90.6  15.7† 88.9  10.2 89.3  17.3 <0.001
Diabetes mellitus 1.7 2.5 1.5 1.2 1.3 0.1
Antidiabetic drugs 1.5 2.1 1.2 1.2 1.2 0.31
Total cholesterol, mg/dl 200.0  34.3 202.0  34.3 200.0  32.6 200.0  33.3 203.0  33.0 0.443
HDL cholesterol, mg/dl 49.2  12.2 47.2  11.8† 49.0  11.7† 50.9  12.8 50.8  13.4 <0.001
LDL cholesterol, mg/dl 132.0  29.8 134.0  30.6 132.0  28.8 131.0  29.9 133.0  31.9 0.135
Triglycerides, mg/dl 94.5  57.3 100.7  61.1† 94.4  55.0 89.1  50.7 95.5  88.3 <0.001
Lipid-lowering drugs 6.9 8.3 8.0 4.7 4.4 0.001
Metabolic syndrome‡ 9.5 12.6 8.8 8.0 6.9 <0.001
STOP-BANG score§ 1.3  1.1 1.6  1.1† 1.3  1.02† 1.1  0.9 1.0  1.0 <0.001
STOP-BANG score $3§ 13.2 18.9 13.2 9.0 6.2 <0.001
CRP, mg/dl 0.10 (0.05–0.19) 0.11 (0.05–0.20) 0.09 (0.05–0.18) 0.09 (0.05–0.19) 0.09 (0.05–0.17) 0.07
VCAM, ng/ml 617 (490–765) 593 (476–747) 621 (494–769) 627 (498–772) 630 (488–774) 0.006
P-selectin, ng/ml 129 (104–154) 133 (108–157) 129 (104–154) 127 (102–151) 122 (96–140) 0.002
Neutrophil, % 57.6 (52.5–62.8) 57.8 (52.8–63.4) 57.3 (52.4–62.2) 57.6 (52.3–62.8) 58.3 (52.2–64.1) 0.23
Use of benzodiazepine and
its derivatives
6.8 6.2 6.8 6.5 13.8 0.012
Values are n (%), mean  SD, %, or median (quartile 1, quartile 3). Bold indicates statistical significance. *p values for continuous variables in this column reflect p for trend.
†p<0.05 vs. RSD (reference group). ‡National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria. §Modified score. Neck circumference not
available.
BMI ¼ body mass index; BP ¼ blood pressure; CRP ¼ C-reactive protein, HDL ¼ high-density lipoprotein; LDL ¼ low-density lipoprotein; LSD ¼ long sleep duration;
MVPA ¼moderate to vigorous physical activity; RSD ¼ reference sleep duration; STOP-BANG¼ Snoring, Tired, Observed apnea, high blood Pressure, BMI >35 kg/m2, Age >50,
Neck circumference >43 cm in males and >41 cm in females, and male Gender; SSD ¼ short sleep duration; VCAM ¼ vascular cell adhesion molecule; VSSD ¼ very short sleep
duration.
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137p values when compared with the reference group.
The chi-square test was used for categorical variables.
The degree of agreement between actigraphic
and self-reported sleep duration was quantified by
computing a concordance correlation coefficient.
Associations between actigraphic sleep parameters
(fragmentation index and sleep duration) and car-
diometabolic risk outcomes or inflammation markers
were evaluated by multivariable ordinal regression
models adjusted for age, sex, physical activity,
BMI, smoking status, alcohol consumption, systolic
blood pressure, education level, fasting glucose,
total cholesterol, total kcal per day, marital status,
CES-D/PSS, and mSTOP-BANG questionnaire scores.
Moreover, to obtain p values for the overall adjustedassociation between sleep parameters and athero-
sclerosis variables, we performed a likelihood-ratio
test comparing the final models and the model
including all variables other than the predictive
variable in each analysis.
As sex has been reported to modify the association
between sleep and cardiometabolic parameters (35),
associations were additionally explored separately in
men and women when a test for significance of effect
modification by sex showed a p value <0.05.
RESULTS
A total of 2,488 men (62.6%) and 1,486 women
(37.4%) underwent actigraphic analysis to evaluate
TABLE 2 Cardiovascular Risk Scales According to Sleep Duration and Fragmentation
Total Sleep
Time (Actigraph) Total VSSD <6 h SSD 6 to <7 h RSD 7 to <8 h (Ref) LSD $8 h p Value*
CVD risk scales
FRS 10% 5.9  4.4 6.9  4.8† 5.9  4.3† 5.0  3.8 5.1  4.6 <0.001
FRS 30% 17.7  11.8 20.9  12.7† 17.7  11.4† 15.2  10.6 15.6  12.3 <0.001
Fuster-BEWAT score <0.001
Poor 6.5 9.3 5.6 5.5 4.4
Intermediate 60.1 63.4 62.2 55.6 51.6














FRS 10% 5.0  3.8 5.4  3.9 5.9  4.4† 6.3  4.9† 6.8  4.7† <0.001
FRS 30% 15.2  10.3 16.6  10.9 17.5  11.4† 18.8  12.6† 20.4  12.8† <0.001
Fuster-BEWAT score <0.001
Poor 4.5 5.8 6.2 7.2 9.0
Intermediate 57.8 59.8 59.7 58.3 64.8
Ideal 37.7 34.4 34.1 34.5 26.2
Values are mean  SD or %. Post hoc Bonferroni analysis. Bold indicates statistical significance. *p values for continuous variables in this column reflect p for trend. †p < 0.05
compared with reference group.
FRS ¼ Framingham risk score; Ref ¼ reference.
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138sleep duration and quality. The proportion of partic-
ipants with RSD was 30.7%, whereas SSD or VSSD
accounted for 65.3% of cases. Only 4% of participants
presented LSD (Table 1). Regarding sleep fragmenta-
tion, each of the quintiles comprised 774 to 786 par-
ticipants (Online Table 1).
There was a significant but weak correlation be-
tween actigraphic and self-reported sleep duration
among the study participants (Pearson correlation
coefficient: 0.35; p < 0.001). Moreover, the 3,899
subjects who answered the questionnaires over-
estimated their sleep duration as compared with the
accelerometer results (Online Figure 1).
CLINICAL PROFILE AND SLEEP PARAMETERS.
Baseline characteristics according to actigraphy-
measured sleep duration are presented in Table 1.
Increased age, higher systolic and diastolic blood
pressure hypertension, BMI, lower HDL cholesterol,
and metabolic syndrome were significantly more
prevalent in participants with VSSD or SSD compared
to RSD (7 to 8 h) (Table 1). Similar to VSSD and SSD,
participants in the higher quintile for SFI were
significantly older and had an increased prevalence of
smoking and hypertension (Online Table 1).
The Framingham risk score for 10 and 30 years
estimated a significantly higher cardiovascular risk in
participants with VSSD or SSD compared with RSD as
well as in those included in the 3 higher quintiles of
sleep fragmentation. The same findings were
observed with the recently described Fuster-BEWAT
score (20) (Table 2). No differences were foundregarding psychosocial characteristics according to
sleep duration and fragmentation (Online Table 2).
ASSOCIATION OF SLEEP DURATION AND QUALITY
WITH SUBCLINICAL ATHEROSCLEROSIS. Three-
dimensional VUS in carotid and femoral territories
was available for analysis in 3,804 participants
(Online Table 3). When adjusted for age, sex, mod-
erate to vigorous physical activity (MVPA), BMI,
smoking status, alcohol consumption, systolic blood
pressure, education level, fasting glucose, total
cholesterol, total kcal per day, marital status, CES-D,
PSS, and mSTOP-BANG questionnaire scores, VSSD
was independently associated with an increased pla-
que burden compared with the reference group (sleep
duration 7 to 8 h) (odds ratio [OR] of being in the
highest tertile of plaque burden: 1.27; 95% confidence
interval [CI]: 1.06 to 1.52; p ¼ 0.008) (Table 3, Central
Illustration). The ordinal regression analysis consid-
ering tertiles for 3D plaque burden and number of
diseased territories also showed that participants who
slept <6 h presented a trend toward a more extensive
atherosclerosis with a higher number of affected
vascular territories, but the differences were not sig-
nificant (OR of presenting more affected territories:
1.21; 95% CI: 1.02 to 1.45; p ¼ 0.03, but overall test
p value ¼ 0.18). The association between subclinical
atherosclerosis and sleep duration was also investi-
gated using the Sleep Habits Questionnaire. In this
case, no statistically significant differences in plaque
burden or CAC score were observed between the
different sleep groups in the overall association tests
TABLE 3 Atherosclerotic Plaque Burden and Number of Affected Territories Measured by 3D Echocardiography and Sleep Duration: Comparison Between
Self-Reported Sleep and Actigraphy
Actigraph Sleep Habits Questionnaire
Noncoronary Plaque Burden






OR 95% CI p Value OR 95% CI p Value OR 95% CI p Value OR 95% CI p Value
Total sleep duration, h 0.045* 0.18* 0.33* 0.20*
<6 1.27 1.06–1.52 0.008 1.21 1.02–1–45 0.03 0.99 0.79–1.24 0.92 0.92 0.74–1.16 0.50
6–7 1.10 0.94–1.30 0.25 1.07 0.90–1.26 0.40 1.13 0.98–1.31 0.10 1.13 0.98–1.31 0.09
7–8 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
>8 1.31 0.92–1.85 0.13 1.13 0.79–1.13 0.50 0.91 0.78–1.34 0.50 1.03 0.78–1.34 0.86
Men sleep duration, h 0.32* 0.41* 0.27* 0.22*
<6 1.21 0.98–1.49 0.08 1.14 0.93–1.41 0.21 1.15 0.88–1.50 0.32 1.06 0.81–1.39 0.69
6–7 1.13 0.93–1.38 0.23 1.04 0.85–1.27 0.71 1.23 1.03–1.46 0.02 1.21 1.02–1.44 0.03
7–8 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
>8 0.96 0.59–1.56 0.87 1.13 0.79–1.13 0.44 0.99 0.69–1.43 0.96 1.08 0.75–1.55 0.68
Women sleep duration, h 0.02* 0.11* 0.37* 0.33*
<6 1.48 1.06–2.07 0.02 1.38 1.00–1.93 0.053 0.69 0.44–1.07 0.10 0.68 0.44–1.05 0.08
6–7 1.01 0.76–1.36 0.90 1.04 0.85–1.27 0.44 0.94 0.72–1.23 0.66 0.97 0.74–1.26 0.81
7–8 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
>8 1.83 1.12–3.01 0.02 1.65 1.01–2.72 0.05 0.77 0.51–1.18 0.23 0.89 0.59–1.35 0.59
Odds ratios (ORs) and 95% confidence intervals (CIs) of total plaque burden measured by 3-dimensional echocardiography (carotid and femoral territories) and affected territories in the different groups
according to sleep duration compared with the reference group (7 to 8 h of sleep). Ordinal regression model adjusted for age, sex, moderate to vigorous physical activity, body mass index, smoking status,
alcohol consumption, systolic blood pressure, education level, fasting glucose, total cholesterol, total kcal/day, marital status, Center for Epidemiological Studies-Depression, Perceived Stress Scale, and
mSTOP-BANG questionnaire scores. Total plaque burden was divided into no plaque and tertiles (men: 0, 1.09 to 31.98, 31.99 to 105.62, and 106.53 to 1,241.98 mm3; women: 0, 1.19 to 14.83, 15.02 to
38.89, and 40.69 to 536.34 mm3). *p values for the overall adjusted associations for each analysis (likelihood-ratio test). The other p values correspond to pairwise comparisons with the reference group.
Abbreviations as in Table 1.
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139(Table 3), further highlighting the importance of
objective sleep data for these kinds of studies.
The same analysis was performed to evaluate the
impact of sleep fragmentation on plaque burden.
We found that the whole cohort and more specifically
male participants with a more fragmented sleep
(fifth quintile) presented a higher number of
affected territories compared to the reference group
(first quintile) (Central Illustration). A subanalysis
excluding subjects with an mSTOP-BANG score $3
(n ¼ 450; 11.8% of study participants with available
3D VUS) was conducted and showed similar results
regarding VSSD and noncoronary atherosclerosis
(Online Table 4). Moreover, in this case, participants
with LSD showed a higher noncoronary plaque
burden, although this difference was specifically
observed in women (OR: 1.95; 95% CI: 1.20 to 3.19;
p ¼ 0.007 vs. OR: 1.07; 95% CI: 0.64 to 1.80; p ¼ 0.80
in men).
Next, we investigated the relationship between
sleep patterns and CACS. Coronary CT was available
for analysis in 3,899 participants. Patients in the VSSD
and SSD groups, as well as those with more disrupted
sleep (fifth quintile), were associated with a higher
CACS (Online Table 5). Adjusting for the aforemen-
tioned confounding factors, CACS was not signifi-
cantly higher in SSD, VSSD, or LSD participantsregardless of the method used for the evaluation of
sleep habits (Online Table 4). Similarly, no significant
association was observed between sleep quality
and CACS in the variable-adjusted analysis or after
excluding subjects with an mSTOP-BANG score $3
(Figure 1, Online Table 6).
ASSOCIATION OF DIETARY INTAKE AND INFLAMMATION
WITH SLEEP PARAMETERS. No differences were
observed between the different sleep duration groups
when the quantity of nutrients was adjusted to grams
in 2,000 kcal/day (Online Table 7). However, partici-
pants in the VSSD group presented a higher daily
intake of alcohol, and those included in the VSSD
and SSD groups presented a higher intake of caffeine
compared with participants in the RSD group (Online
Table 7). Similarly, participants in the higher quintile
of SFI presented a higher intake of alcohol and
caffeine compared with the reference group, and also
an increased total energy intake (Online Table 8).
We next investigated the association between
inflammation markers and sleep patterns. P-selectin
and hs-CRP were significantly higher in VSSD partic-
ipants (Table 1) and hs-CRP values were significantly
higher in the higher quintile of FI compared with
the lower quintile (Online Table 1). However, neither
VSSD nor SSD were associated with a higher level
CENTRAL ILLUSTRATION Sleep Duration and Quality Versus Subclinical Atherosclerotic Burden
<6 h: Very short sleep duration
7-8 h: Reference sleep duration
6-7 h: Short sleep duration
>8 h: Long sleep duration
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Forest plots showing the odds ratios (ORs) and confidence intervals (CIs) of total plaque burden measured by 3D echocardiography (carotid and femoral territories) in
the different groups according to actigraphic sleep duration and fragmentation compared with the reference group (7 to 8 h of sleep, quintile 1). Ordinal regression
model adjusted for age, sex, moderate to vigorous physical activity, body mass index, smoking status, alcohol consumption, systolic blood pressure, education level,
fasting glucose, total cholesterol, total kcal/day, marital status, Center for Epidemiological Studies-Depression scale, Perceived Stress Scale, and mSTOP-BANG
(modified Snoring, Tired, Observed apnea, high blood Pressure, BMI >35 kg/m2, Age >50, Neck circumference >43 cm in males and >41 cm in females, and male
Gender) questionnaire scores. The p values (bold indicates statistical significance) for the overall adjusted association between sleep parameters and atherosclerosis
variables correspond to: sleep duration versus noncoronary plaque burden: p [ 0.045 (men: p ¼ 0.32; women: p [ 0.02); sleep fragmentation versus noncoronary
plaque burden: p [ 0.004 (men: p [ 0.02; women: p ¼ 0.09). Total plaque burden divided in no plaque and tertiles (men: 0, 1.09 to 31.98, 31.99 to 105.62, and
106.53 to 1241.98 mm3; women: 0, 1.19 to 14.83, 15.02 to 38.89, and 40.69 to 536.34 mm3). Sleep fragmentation index values fifth quintile: 7.39 to 43.43; fourth
quintile: 5.29 to 7.38; third quintile: 4.04 to 5.29; second quintile: 2.88 to 4.04; first quintile (reference group): 0.23 to 2.88. 3D ¼ 3-dimensional; CT ¼ computed
tomography; LSD ¼ long sleep duration; RSD ¼ reference sleep duration; SFI ¼ sleep fragmentation index; SSD ¼ short sleep duration; VSSD ¼ very short sleep
duration; VUS ¼ vascular ultrasound.
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(Online Table 9).
DISCUSSION
Our study shows that objectively assessed sleep
duration and sleep fragmentation are independently
associated with subclinical atherosclerosis after
adjusting for cardiovascular risk factors and OSA risk.
Unlike previous studies, the atherosclerotic plaque
burden was accurately assessed by 2 imaging tech-
niques including 3D VUS and coronary CT. Because
various vascular territories were evaluated, this is the
first study to report the impact of actigraphic sleep
parameters on multiterritorial atherosclerosis, and isthe biggest cohort with objectively measured sleep
in this regard published to date. Furthermore, sub-
jects diagnosed with obstructive sleep OSA were
excluded, and the results were adjusted for the
potential presence of OSA based on an mSTOP-BANG
questionnaire score, thereby avoiding the confound-
ing effect of this sleep disorder on our analysis.
We observed that participants sleeping <6 h/night
(VSSD group) present a higher burden of noncoronary
atherosclerosis and those with most fragmented
sleep (fifth FI quintile) show in addition a higher
number of affected territories measured by 3D VUS,
independently of the presence of conventional CVD
risk factors. Furthermore, LSD was related to a higher
atherosclerotic burden specifically in women.
FIGURE 1 Coronary Artery Calcium Score Versus Actigraphic Sleep Duration and Fragmentation Index
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Forest plot showing the odds ratios and confidence intervals of coronary artery calcium (CAC) scores in the different groups according to sleep
duration fragmentation compared to the reference groups (7 to 8 h and first quintile, respectively). CAC score was divided into the following
groups according to Agatston score: <1, 1 to 100, 100 to 400, >400. Ordinal regression model adjusted for age, sex, moderate to vigorous
physical activity, body mass index (BMI), smoking status, alcohol consumption, systolic blood pressure, education level, fasting glucose, total
cholesterol, total kcal/day, marital status, Center for Epidemiological Studies-Depression, Perceived Stress Scale, and mSTOP-BANG
(modified Snoring, Tired, Observed apnea, high blood Pressure, BMI >35 kg/m2, Age >50, Neck circumference >43 cm in males and >41 cm
in females, and male Gender) questionnaire scores. The p values for the overall adjusted association between sleep parameters and CAC score
correspond to (bold indicates statistical significance): sleep duration versus CAC score$1: p ¼ 0.44 (men: p ¼ 0.47; women: p ¼ 0.70); sleep
fragmentation versus CAC score $1: p [ 0.02 (men: p ¼ 0.12; women: p ¼ 0.08). Total plaque burden divided in no plaque and tertiles
(men: 0, 1.09 to 33.70, 33.71 to 107.69, 108.03 to 1,241.98, and >1,241.98 mm3; women: 0, 1.19 to 16.32, 16.56 to 45.24, 45.49 to 536.34,
and >536.34 mm3). Sleep fragmentation index values fifth quintile: 7.39 to 43.43; fourth quintile: 5.29 to 7.38; third quintile: 4.04 to 5.29;
second quintile: 2.88 to 4.04; and first quintile (reference group): 0.23 to 2.88. CI ¼ confidence interval; OR ¼ odds ratio.
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quality had an effect on CACS or inflammation bio-
markers in our study population.
In our study, participants with SSD or VSSD pre-
sented a higher prevalence of classical cardiovascular
risk factors, which is consistent with previously pub-
lished data (3,6,36–38). Consequently, individuals
with poorer sleep presented higher scores in various
cardiovascular risk scales (Table 2). Moreover, partic-
ipants with VSSD, SSD, and a more fragmented
sleep (fourth and fifth quintiles) were moreoverweight (>26 kg/m2) and those with LSD and non-
fragmented sleep presented with lower BMI values
(Table 1, Online Table 1).
The link between short sleep duration and higher
energy intake has already been suggested (39), but
the most extensive related study published to date
relied on self-reported sleep measurements (40)
and the only available actigraphy-based study was
restricted to women (41). In our study, only subjects
with the most disrupted sleep (quintile 5) presented a
higher energy intake, but the fats, carbohydrates, or
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142proteins did not differ significantly between sleep
groups. Only alcohol and caffeine consumption were
higher in participants with short and disrupted sleep
(Online Tables 5 and 6). Lately, coffee intake has been
associated with better cardiovascular outcomes and
lower mortality (42), but in our study, a higher
caffeine intake seems to be related to unhealthier
sleep patterns in groups with more cardiovascular
risk factors.
These results support that subjects with poor sleep
hygiene are clustered into groups apparently less
engaged in healthy cardiovascular behaviors. How-
ever, apart from confirming the direct association of
sleep duration and quality with cardiovascular risk
factors and dietary habits, the current study is the
first to show that objectively measured sleep is
independently associated with subclinical multi-
territory atherosclerosis. The fact that sleep duration
and quality was objectively measured is relevant, as
we have observed that self-reported sleep duration
may not be reliable. In our study, while 27.1% of
participants slept <6 h/day according to the acceler-
ometer, only 10.7% reported <6 h sleep in the Sleep
Habits Questionnaire. Consequently, the association
of self-reported sleep with noncoronary atheroscle-
rosis in our study is different from that seen with
actigraphy, and only the subgroup of men who
slept 6 to 7 h showed a trend toward a higher risk of
noncoronary atherosclerosis (Table 3). This could be
explained by the fact that these participants actually
present with VSSD rather than SSD.
The largest study to date that analyzed the impact
of sleep on atherosclerosis with objectively measured
sleep parameters (n ¼ 1,844) included subjects with
OSA, and the clinical endpoint was peripheral artery
disease measured with ankle-brachial index (14).
Another study with 1,465 participants showed that
poorer sleep was associated with greater coronary
artery calcification (13). However, the effect of sleep
patterns on subclinical atherosclerosis in a population
without sleep-related disorders has not been
adequately studied until now. In the present study,
roughly 3,800 participants underwent coronary CT
and 3D VUS in different territories. An association
with CACS was discarded after adjusting for con-
founders, but the association with higher non-
coronary atherosclerotic burden was significant. This
may be explained by the fact that 3D VUS is a more
sensitive technique than CACS to measure early
atherosclerosis (32).
Regarding LSD, despite the result of a previous
meta-analysis that found a correlation with cardio-
vascular outcomes (1), its effect on subclinical
atherosclerosis remains unresolved due to variableresults in previous studies (8). We have observed that
LSD is not associated with plaque burden or CACs in
the general cohort. However, the subgroup of women
who slept >8 h presented with a higher burden of
subclinical atherosclerosis, and similar results were
observed in the general cohort after excluding
participants with an mSTOP-BANG score $3 (Online
Table 4). As the number of patients with LSD was
limited, these results need validation in a bigger
cohort. In any case, these findings suggest that
too-long sleep duration may not be healthy either,
and recommendations should be restricted to 7 to 8 h
of sleep.
Overall, our findings support the potential role of
healthy sleeping in protecting against atherosclerosis.
Thus, recommending a good sleep hygiene should be
part of the lifestyle modifications provided in our
daily clinical practice.
STUDY LIMITATIONS. The PESA study cohort is rela-
tively homogeneous and may not be representative of
the general population, as it includes onlymiddle-aged
subjects with generally low cardiovascular risk and a
characteristic occupation and lifestyle. Although sub-
jectswith an establishedOSA diagnosiswere excluded,
this condition is usually underdiagnosed in the general
population. Thus, the results were adjusted for an
mSTOP-BANG questionnaire score with the available
clinical data in the PESA study. The original STOP-
BANG questionnaire could not be used due to the lack
of neck circumference data. A definite OSA evaluation
would need a polysomnography study in all study
participants, which was not available. In addition,
whereas wrist actigraphy might be the preferred
method for sleep evaluation, in this study we used
waist actigraphy. However, previous studies have
shown a good correlation between polysomnography
and waist actigraphy data (43).
Furthermore, the LSD group represents only 4% of
the total cohort, and results are not as generalizable
as in the other groups. Finally, as follow-up data is
not included in the study, the effects of sleep patterns
on subclinical atherosclerosis over time are not
addressed.
However, the proportion of women participants is
higher than in other studies, and sleep and clinical
data are well characterized in this cohort, which are
both strengths of this study.
CONCLUSIONS
Sleep is an important factor influencing cardiovascular
health and could have a role as a marker of subclinical
atherosclerosis. Objectively measured short sleeping
times and fragmented sleep are associated with an
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Metabolic syn-
drome is associated with abnormal sleep patterns. Short and
fragmented sleep patterns are independently associated with
increased atherosclerotic plaque burden in middle-aged
individuals.
TRANSLATIONAL OUTLOOK: Prospective studies are needed
to assess the impact of specific interventions that improve sleep
hygiene on clinical ischemic events.
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143increased risk of subclinical atherosclerosis. These
results highlight the importance of healthy sleep
habits for the prevention of CVD.
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